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doi:10.1Objective: Survivin, an important inhibitor of apoptosis, is overexpressed in esophageal cancer and negatively
affects survival. The complex regulation of survivin transcription involves enhancement by beta-catenin and
repression by p53. The purpose of this study is to test whether inhibition of beta-catenin or overexpression of
p53 can decrease survivin expression and render esophageal cancer cells more susceptible to apoptosis.
Methods: Studies were performed in normal human esophageal epithelial cells and the human esophageal cancer
cell line TE7. Levels of beta-catenin, survivin, and p53 were measured by Western blot. Apoptosis was induced
after treatment with camptothecin and measured by release of caspase 3 and morphologic criteria. The roles of
survivin and beta-catenin in preventing apoptosis were tested by their silencing with specific small interfering
RNA molecules. The effect of p53 overexpression on survivin promoter activity was measured using a survivin
promoter-luciferase reporter construct and by real-time polymerase chain reaction measurement of survivin
mRNA levels.
Results: Both beta-catenin and survivin are overexpressed in TE7 cells, whereas p53 expression is negligible.
TE7 cells demonstrate resistance to camptothecin-induced apoptosis (P<.01). This effect is significantly reduced
by inhibition of survivin, but not of beta-catenin (P< .01). Overexpression of p53 in TE7 cells reduces survivin
transcription and mRNA levels (P< .01), without reducing survivin protein levels.
Conclusion: Survivin plays a critical role in TE7 cell resistance to camptothecin-induced apoptosis. This effect is
not dependent on beta-catenin expression. Overexpression of p53 decreases survivin transcription but does not
decrease levels of survivin protein, suggesting posttranscriptional control of survivin expression. (J Thorac
Cardiovasc Surg 2010;140:225-32)There are more than 16,000 new cases of esophageal cancer
diagnosed each year in the United States. Despite advances
in radiographic and endoscopic detection, chemoradiation
therapy, and surgical care, the overall 5-year survival for pa-
tients diagnosed with esophageal cancer is 17%.1 Most
treatment failures result from distant metastatic disease unre-
sponsive to systemic chemotherapy. Identification of the in-
tracellular changes responsible for the development and
progression of esophageal cancer provides a potential oppor-
tunity for designing rational targeted therapies for the treat-
ment of this lethal disease.
One of the major modes of action of chemotherapy and ra-
diation therapy in the treatment of cancer is the activation of
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Seffector genes p21, mdm-2, and gadd45 are important compo-
nents in the cellular response to radiation and chemotherapy-
induced damage.2,3 In addition, a number of members in the
Bcl-2 and inhibitor of apoptosis families of proteins (includ-
ing survivin) have been shown to be overexpressed in cancer
cells and demonstrate marked antiapoptotic function. Because
the intracellular mechanisms associated with resistance to ap-
optosis in cancer cells seem to be tissue specific, we sought to
specifically investigate the mechanisms responsible for apo-
ptosis resistance in esophageal cancer cells.
Survivin is a member of the inhibitor of apoptosis family
of proteins and is an important downstream effector of b-cat-
enin/T-cell factor (TCF)-mediated transcription.4-7 Survivin
is normally expressed during the G2/M phase of the cell
cycle and associates with microtubules of the mitotic spin-
dle. Overexpression of survivin functions to overcome this
apoptotic checkpoint and favors the aberrant progression
of transformed cells through mitosis.8 Although survivin is
almost undetectable in most normal human adult tissues, it
is highly expressed in a number of cancers, including esoph-
ageal cancer.9-11
The Wnt signaling cascade is important for maintaining
epithelial integrity throughout the gastrointestinal tract.
Wnt signaling induces growth-promoting (c-myc, cyclinrdiovascular Surgery c Volume 140, Number 1 225
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catenin/TCF-mediated transcription.12-14 We previously
demonstrated that the Wnt signaling cascade is overex-
pressed in esophageal cancer cells and that down-regulation
of b-catenin inhibited esophageal cancer cell proliferation
and induced spontaneous apoptosis. In addition, inhibition
of b-catenin in esophageal cancer cells was associated
with decreased b-catenin/TCF-mediated transcription and
decreased expression of the downstream effectors of Wnt-
signaling, including the multidrug resistance gene and the
transcription factor LEF-1.15
BecauseWnt signaling has beendemonstrated to induce ex-
pression of survivin through b-catenin/TCF-mediated tran-
scription, we initially hypothesized that this mechanism was
responsible for the resistance to apoptosis observed in esoph-
ageal cancer cells. The results presented in this study demon-
strate that inhibition of survivin expression induced both
spontaneous apoptosis and augmented chemotherapy-induced
apoptosis in esophageal cancer cells. However, inhibition of
b-catenin expression had no effect on survivin protein expres-
sion or spontaneous or chemotherapy-induced apoptosis. Ad-
ditional experiments demonstrated that overexpression of
wild-type p53 protein in esophageal cancer cells resulted in
a marked decrease in survivin transcription, but no decrease
in survivin protein levels. Taken together, these results are
consistent with a model of esophageal cancer cell resistance
to apoptosis in which loss of p53 leads to increased survivin
gene transcription and additional posttranscriptional regula-
tion facilitates increased survivin protein expression.MATERIAL AND METHODS
Cell Lines and Cell Culture
The human esophageal cancer cell line TE7 was received as a gift from
Dr Nishihira. It was derived from an esophageal adenocarcinoma and char-
acterized in the Cell Resource Center for Biomedical Research, Tohoku
University. This cell line was cultured in Roswell Park Memorial Institute
(Mediatech Inc, Herndon, Va) supplemented with 10% heat-inactivated fe-
tal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin mixture
(all fromMediatech Inc), and maintained in a 37 C incubator with 5%CO2
humidified air. Normal human esophageal (nhEso) mucosal cells were de-
rived from human esophageal specimens harvested at the time of donor
lung procurement. Esophageal specimens were opened and washed with
sterile medium. The mucosa was then removed by careful dissection along
the submucosal plane separating the mucosal and muscular layers of the
esophagus. This mucosal layer was then cut into small pieces and digested226 The Journal of Thoracic and Cardiovascular Surgin a collagenase medium to create a single cell suspension. These esopha-
geal mucosa cells were then maintained in BEBM media (Lonza Corpora-
tion, Walkersville, Md) supplemented with 20% heat-inactivated fetal
bovine serum and the BEGM BulletKit. Passages 5 to 20 were used for
the experiments. Stock cells were maintained in T-150 flasks and incubated
at 37C in a humidified atmosphere of 95% air and 5% CO2.
Western Blot Analysis
Whole-cell lysates were prepared using 2% sodium dodecyl sulfate sam-
ple buffer (250 nM Tris$HCl, pH 6.8, 2% sodium dodecyl sulfate, 20%
glycerol, and 5% mercaptoethanol), vortexed, and centrifuged (14,000g)
at 4C for 10 minutes. The supernatants from cell samples were boiled
for 5 minutes and then subjected to electrophoresis on 10% or 15% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. After transferring pro-
teins onto nitrocellulose filters, the blots were incubated for 1 hour in 5%
nonfat dry milk in 13 tris-buffered saline/tween 20 (TBS-T). Immunologic
evaluation was then performed for 1 hour in 5% nonfat milk/TBS-T buffer
containing the specific antibody against b-catenin, survivin, and caspase-3
proteins. The filters were subsequently washed with 13 TBS-T and incu-
bated for 1 hour with the appropriate secondary antibody conjugated to
horseradish peroxidase. After extensive washing with 13 TBS-T, the im-
munocomplexes on the filters were reacted for 1 minute with Chemilumi-
nescence Reagent (NEL-100; NEN, Boston, Mass), and exposed to
autoradiography film for 10 to 60 seconds.
RNA Interference
The small interfering (si)RNA specifically targeting the coding region of
b-catenin mRNA (sib-catenin) was purchased from Dharmacon (Chicago,
Ill). The siRNA that was designed to specifically cleave survivin mRNA (si-
Survivin) was purchased from Cell Signaling Technology (Boston, Mass).
Scrambled control siRNA (C-siRNA), which had no sequence homology to
any known genes, was used as the control. For each 100-mm cell culture
dish of the sib-catenin transfection, 20 mL of the 10 mM stock duplex sib-
catenin or C-siRNA was mixed with 600 mL of Opti-MEM medium (Invi-
trogen, Carlsbad, Calif). For the siSurvivin transfection, 40 mL of the 10 mM
stock duplex siSurvivin or C-siRNA was mixed with 600 mL of Opti-MEM
medium. The mixture was gently added to a solution containing 10 mL of
Lipofectamine 2000 (Invitrogen) in 600 mL of Opti-MEM. The solution
was incubated for 20 minutes at room temperature and gently overlaid
onto monolayers of cells in 6 mL of medium. Cells were harvested for var-
ious assays after 72 hours of incubation.
Determination of Apoptosis
To examine the apoptotic responses of nhEso and TE7 cell lines, we used
a camptothecin-induced apoptosis model. After either no manipulation or
treatment with indicated siRNA molecules, cells were cultured in serum-
free media for 18 hours before the addition of camptothecin (10 mM) for
6 hours. Cells were photographed with a Nikon inverted microscope
(Tokyo, Japan) before the preparation of whole cell lysates to be used for
the detection of caspase-3. The number of apoptotic cells was quantified us-
ing a morphologic analysis described previously.16 Briefly, representative
photomicrographs were reviewed by 2 observers. Between 100 and 150
cells were counted, and the number of apoptotic cells were expressed as
a fraction of the total number of cells counted.
Reverse Transcription-Polymerase Chain Reaction
and Real-Time Polymerase Chain Reaction Analysis
Total RNAwas isolated by using the RNeasy mini kit (QIAGEN, Valen-
cia, CA) and used in reverse transcription and polymerase chain reaction
(PCR) amplification reactions. Real-time quantitative PCR was performed
using 7500-Fast Real-Time PCR Systems (Applied Biosystems, Foster
City, Calif) with specific primers, probes, and software (Applied Biosys-
tems). The levels of survivin mRNA were quantified by quantitative PCRery c July 2010
FIGURE 1. TE7 cells overexpress survivin and b-catenin and are resistant
to chemotherapy-induced apoptosis compared with nhEso cells. A, Repre-
sentative immunoblot of whole cell lysates from nhEso and TE7 cells.
Twenty-five milligrams of total protein were applied to each lane, and mem-
branes were hybridized with the antibody specific for survivin (16 kDa)
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nase levels.
Reporter Plasmids and Luciferase Assays/Plasmid
Construction and Transfection
Genomic cloning and sequence analysis. Two PCR primers
designed from the human survivin gene were used to amplify human geno-
mic DNA. The sequences of the primers were 5’-CTG GCC ATA GAA
CCA GAG AAG TGA-3’ (sense) and 5’-CCA CCT CTG CCA ACG
GGT CCC GCG-3’ (antisense). After the resulting PCR product was se-
quenced to confirm that no mutations were introduced by PCR, the product
obtained was subcloned into an expression vector pCR 2.1 by using a TA
cloning kit (Invitrogen). One positive clone was identified. Recombinant
DNA was prepared using PureYield Plasmid Miniprep System (Promega,
Madison, Wis) according to the manufacturer’s instructions. Xho I and
Hind III digestion of the clone resulted in a 1.1-kb fragment that was
then subcloned into the pGL3-Basic Vector (Promega). Sequencing analy-
sis of clone was found to contain 1.1 kb of the survivin 5’ flanking
sequence.
Transfection and luciferase assay. nhEso and TE7 cells were
seeded in 12-well plates 24 hours before transfection at a density of 6
3 104 or 3 3 105 cells per well, respectively. At 50% to 60% confluence,
cells were transfected using Lipofectamine 2000 according to the manu-
facturer’s suggestion. The cells were incubated with Lipofectamine:DNA
complexes containing 0.7 mL of Lipofectamine, 0.3 mg of test plasmid,
and 0.15 mg of a control plasmid containing the Renilla luciferase reporter
gene under the control of a cytomegalovirus enhancer/promoter (Prom-
ega). The transfection mixture was replaced by regular growth medium
6 hours later. Measurement of luciferase activity was performed 24 hours
after transfection by using the Dual Luciferase Reporter Assay System
(Promega) according to the manufacturer’s protocol. Briefly, cells were
washed twice with PBS solution and solubilized with 100 mL of lysis
buffer. The lysates were collected, and luciferase assay was determined
by using 20-mL aliquots of supernatants using a Microtiter Plate Lumin-
ometer and Revelation 4.06 Software (Dynex Technologies, Chantilly,
Va). The luciferase activity of each construct was compared with that of
the promoterless pGL3 basic vector. The levels of luciferase activity
from individual constructs were normalized by Renilla-driven luciferase
activity in every experiment. Luciferase values are expressed as relative
to the highest value obtained in each experiment. Co-transfection assays
were carried out in nhEso and TE7 cells using 0.3 mg of survivin luciferase
reporter gene plasmid, 0.3 mg of either an empty expression vector or an
overexpression vector encoding the tumor protein p53 (OriGene Technol-
ogies Inc, Rockville, Md), in 0.7 mL Lipofectamine reagent. The cells were
harvested 24 hours after transfection and assayed for luciferase activity as
described above.
Statistics
Values are means  standard error from 3 to 6 samples. Autoradio-
graphic and immunoblotting results were repeated 3 times. The significance
of the difference between means was determined by analysis of variance.and b-catenin (42 kDa). After the blot was stripped, actin (42 kDa) im-
munoblotting was performed as an internal control for equal loading. Three
experiments were performed that showed similar results. B, Representative
photomicrographs of apoptotic cell death after treatment with (right) or
without (left) camptothecin (10 mM) for 6 hours. A, nhEso cells. B, TE7
cells. Original magnification 3150. C, Percentage of apoptotic cells as de-
scribed in B. Values are means  standard error (SE) of data from 3 exper-
iments. *P<.01 comparing nhEso cells with TE7 cells after treatment with
camptothecin. nhESO, Normal human esophageal.
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FIGURE 2. Down-regulation of survivin induces spontaneous apoptosis and enhances chemotherapy-induced apoptosis in TE7 cells. A, Representative
immunoblots of survivin expression in TE7 cells 24, 48, and 72 hours after treatment with siSurvivin. B, Representative immunoblots of survivin and cas-
pase-3 protein expression in TE7 cells after transfection with siSurvivin or C-siRNA and subsequent treatment with camptothecin (10 mM) for 6 hours. C,
Representative photomicrographs of apoptotic cell death in TE7 cells after transfection with siSurvivin or C-siRNA and subsequent treatment with (right) or
without (left) camptothecin using the identical conditions described in B. Original magnification 3150. D, Percentage of apoptotic cells as described in C.
Values are means SE of data from 3 experiments. *P<.01 comparing cells treated with siSurvivin versus C-siRNA.þP<.01 comparing cells treated with
siSurvivin and camptothecin versus C-siRNA and camptothecin. nhESO, Normal human esophageal.
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TE7 Cells Overexpress b-Catenin and Survivin and
Are Resistant to Chemotherapy-Induced Apoptosis
To identify the possible mechanism for the resistance to
apoptosis observed in esophageal cancer cells, we examined
the expression levels of b-catenin and survivin in TE7 cells
relative to nhEso cells. As shown in Figure 1, A, both b-cat-
enin and survivin are overexpressed in TE7 cells compared
with nhEso cells. Because resistance to apoptosis is com-
monly observed in cancer cells, we specifically examined
the ability of the chemotherapy agent camptothecin to induce
apoptosis in nhEso and TE7 cells. As illustrated in Figure 1,228 The Journal of Thoracic and Cardiovascular SurgB and C, TE7 cells are significantly more resistant to chemo-
therapy-induced apoptosis. After exposure to camptothecin,
41.2% (standard error of the mean [SEM], 0.97) of nhEso
cells undergo apoptosis as assessed by morphology com-
pared with only 6.9% (SEM, 0.05) of TE7 cells (P< .01).
Inhibition of Survivin Expression Induces
Spontaneous Apoptosis and Augments
Chemotherapy-Induced Apoptosis in TE7 Cells
To determine whether survivin overexpression was di-
rectly responsible for the resistance to apoptosis observed
in TE7 cells, survivin expression was inhibited usingery c July 2010
FIGURE 3. Down-regulation of b-catenin has no significant effect on survivin levels or apoptosis in TE7 cells. A, Representative immunoblots of b-catenin,
survivin, and caspase-3 protein expression in TE7 cells after transfection with sib-catenin or C-siRNA. Cells were subsequently treated with camptothecin (10
mM) for 6 hours. B, Representative photomicrographs of apoptotic cell death in TE7 cells after transfection with sib-catenin or C-siRNA and subsequent
treatment with (right) or without (left) camptothecin using the identical conditions described in A. Original magnification 3150. C, Percentage of apoptotic
cells as described in B. Values are means  SE of data from 3 experiments. No values exhibited statistically significant differences. nhESO, Normal human
esophageal; si, small interfering.
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induced apoptosis was assessed. As demonstrated in Fig-
ure 2, A, treatment of TE7 cells with siSurvivin was associ-
ated with decreased survivin protein expression with its
maximal effect noted from 48 to 72 hours after transient
transfection. TE7 cells then were transiently transfected
with siSurvivin and subsequently treated with camptothecin.
Spontaneous and chemotherapy-induced apoptosis were
then assessed by both generation of caspase-3 from procas-
pase-3 andmorphology. As seen in Figure 2,B, caspase-3 re-
lease was greatest in the cells treated with siSurvivin and
subsequently treated with camptothecin. As depicted in Fig-
ure 2, C and D, treatment of TE7 cells with siSurvivin in
combination with camptothecin resulted in a significant in-
crease in apoptosis compared with treatment with C-siRNA.
Treatment with siSurvivin resulted in a spontaneous apopto-
sis rate of 15.6% (SEM, 0.65) in TE7 cells, versus 5.8%
(SEM, 1.36) after treatment with C-siRNA (P < .01).The Journal of Thoracic and CaFurthermore, after exposure to camptothecin, 33.9%
(SEM, 0.66) of cells treated with siSurvivin underwent apo-
ptosis compared with 19.2% (SEM, 0.55) of cells treated
with C-siRNA (P<.01). These results indicate that survivin
overexpression is an important mechanism for the resistance
to apoptosis observed in TE7 cells.
Inhibition of b-Catenin in TE7 Cells Has No Effect on
Survivin Expression or Chemotherapy-Induced
Apoptosis
We previously demonstrated that inhibition of b-catenin
expressionwas associatedwith an increase in spontaneous ap-
optosis inTE10 esophageal squamous cancer cells.15Because
b-catenin (in combination with TCF) enhances transcription
of the survivin gene, we hypothesized that overexpression
of b-catenin was responsible for survivin overexpression in
esophageal cancer cells. In these experiments, b-catenin ex-
pression was inhibited using sib-catenin and its effect onrdiovascular Surgery c Volume 140, Number 1 229
FIGURE 4. TE7 cells exhibit a loss of p53 with resulting increased survi-
vin transcription. A, Representative immunoblots of p53 protein expression
in nhEso and TE7 cells. B, Schematic representation of the survivin pro-
moter-luciferase reporter construct that included 2 TCF-b-catenin binding
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duced apoptosis was assessed. As demonstrated in Figure 3,
A, treatment ofTE7cellswith sib-catenin hadno effect on sur-
vivin protein expression. Although caspase-3 release was de-
tectable after exposure to camptothecin, no difference in the
number of cells undergoing apoptosis was detected in com-
parison with C-siRNA (Figure 3, B, C).TE7 Cells Exhibit Loss of p53 Expression Resulting
in Increased Survivin Gene Transcription in
Esophageal Cancer Cells
Although b-catenin is a known transcriptional activator
for the survivin gene and is overexpressed in esophageal
cancer cells, we found that it was not directly responsible
for survivin overexpression. For this reason, we examined
other possible proteins that might regulate survivin expres-
sion. p53 is a known repressor of survivin gene transcription
that mediates its effect by binding to p53 binding sites in the
5’ untranslated region of the survivin gene. As demonstrated
in Figure 4, A, TE7 cells demonstrate minimal p53 protein
expression compared with nhEso cells. To assess the effect
of p53 loss on survivin gene transcription, a luciferase re-
porter construct incorporating the survivin gene promoter
was prepared as illustrated in Figure 4, B. In transient trans-
fection experiments shown in Figure 4, C, using this lucifer-
ase reporter construct, TE7 cells demonstrated 10 times
more luciferase activity than nhEso cells (P ¼ .01). Further-
more, as shown by real-time PCR in Figure 4, D, survivin
mRNA levels were twice as high in TE7 cells versus nhEso
cells (P< .01).Overexpression of Wild-type p53 Results in
Decreased Transcription of Survivin Gene
To determine whether loss of p53 protein was responsible
for the survivin overexpression observed in TE7 cells, wild-
type human p53 was overexpressed in cultured nhEso cells
and in TE7 cells. Overexpression of wild-type human p53
was associated with decreased transcription of the survivin
gene in both nhEso cells and TE7 cells (Figure 5, A). Insites and 1 p53 binding site immediately upstream of the survivin gene.
C, Basal activity of the survivin promoter in nhEso and TE7 cells. Cells
were transfected with the survivin promoter construct, and levels of the lu-
ciferase reporter activity were measured 24 hours later. Results were nor-
malized relative to Renilla-driven luciferase activity and expressed as
means  SE of data from 3 separate experiments. Values are expressed as
relative to the highest value in each experiment. *P<.01 comparing nhEso
and TE-7 cells. D, Basal survivin mRNA levels in nhEso and TE7 cells. To-
tal cellular RNAwas isolated, and survivin mRNA levels were measured by
real-time quantitative PCR analysis. Results are expressed relative to glyc-
eraldehyde-3-phophate dehydrogenase mRNA levels. Values are means 
SE of data from 3 separate experiments. *P<.01 comparing nhEso and TE-
7 cells. nhESO, Normal human esophageal; si, small interfering.
ery c July 2010
FIGURE 5. Effect of p53 overexpression on survivin promoter activity
and survivin mRNA transcription in nhEso and TE7 cells. A, Reporter
gene activity in nhEso and TE7 cells after overexpression of p53. Cells
were co-transfected with the survivin reporter construct and the expression
vector containing human p53 cDNA (p53) or control vector lacking p53
(control) using Lipofectamine (Invitrogen, Carlsbad, Calif). Twenty-four
=
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after p53 overexpression. Similarly, as measured by real-
time PCR, survivin mRNA levels decreased in both cell
types after p53 overexpression (Figure 5, B). In TE7 cells,
survivin mRNA levels were reduced by 50% after p53 over-
expression (P<.01). However, overexpression of wild-type
p53 in esophageal cancer cells had no effect on survivin pro-
tein levels (Figure 5, C), suggesting a posttranscriptional
control point that enhances survivin gene expression.DISCUSSION
Overexpression of survivin is observed in many types of
human cancer, including esophageal cancer,9–11 and is asso-
ciated with aberrant progression of transformed cells through
mitosis.8 The results reported in this study clearly demon-
strate that overexpression of survivin plays an important
role in the resistance to apoptosis observed in TE7 cells.
Down-regulation of survivin expression was associated
with both spontaneous apoptosis and enhanced susceptibility
to chemotherapy-induced apoptosis. Down-regulation of
survivin expression in esophageal squamous cancer cells
has been shown to inhibit tumor cell growth in vitro and in
vivo through increased induction of apoptosis.17 To the
best of our knowledge, however, this is the first report docu-
menting that survivin overexpression mediates the resistance
to apoptosis in esophageal adenocarcinoma cells. Of note,
a recent analysis of the TE7 cell line suggests that this line
may be a squamous cell cancer and not an adenocarcinoma.18
Because we previously demonstrated that down-regula-
tion of b-catenin expression was associated with decreasedhours later, luciferase reporter activity was measured. Results were normal-
ized relative to Renilla-driven luciferase activity and expressed as means
SE of data from 3 separate experiments. Values are expressed as relative to
the highest value in each experiment. *P< .01 comparing control versus
p53 transfected nhEso and *P< .01 comparing control versus p53 trans-
fected TE-7 cells. B, Survivin mRNA levels in nhEso and TE7 cells after
p53 overexpression. Cells were co-transfected with the survivin reporter
construct and the expression vector containing human p53 cDNA (p53)
or control vector lacking p53 (control) using Lipofectamine. Total cellular
RNA was isolated, and survivin mRNA levels were measured by real-
time quantitative PCR analysis. Results are expressed relative to glyceralde-
hyde-3-phophate dehydrogenase mRNA levels. Values are means  SE of
data from 3 separate experiments. *P< .01 comparing control versus p53
transfected nhEso and *P< .01 comparing control versus p53 transfected
TE-7 cells. C, Effect of p53 overexpression on survivin expression in nhEso
and TE7 cells. Cells were transfected with the expression vector containing
human p53 cDNA (p53) or control vector lacking p53 (control) using Lip-
ofectamine. Representative immunoblot of whole cell lysates from nhEso
and TE7 cells is shown. Twenty-five milligrams of total protein were ap-
plied to each lane, and membranes were hybridized with the antibody spe-
cific for survivin (16 kDa) and p53. After the blot was stripped, actin (42
kDa) immunoblotting was performed as an internal control for equal load-
ing. Three experiments were performed that showed similar results. .
nhESO, Normal human esophageal; si, small interfering.
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apoptosis,15 we initially hypothesized that b-catenin/TCF-
mediated transcription of the survivin gene was responsible
for the survivin overexpression observed in TE7 cells. How-
ever, the results from the experiments presented in this arti-
cle clearly demonstrate that down-regulation of b-catenin
had no effect on survivin protein expression or spontaneous
or chemotherapy-induced apoptosis. Our previous results
suggested that down-regulation of b-catenin expression
was associated with the induction of spontaneous apoptosis
in esophageal cancer cells. The different result observed in
the current study can be explained by the more specific
and quantitative assay that was used. Although a caspase-3
release assay was used in both studies, the previous study
used a flow cytometry-based assay that was qualitative.
The morphologic apoptosis assay used in the current study
allowed for a more quantitative analysis of the results.
p53 is known to negatively regulate transcription of the
survivin gene.19 In the current study, TE7 cells have lost
p53 expression and demonstrated increased transcription of
the survivin gene. Overexpression of wild-type human p53
in TE7 cells decreased transcription of the survivin gene
and decreased survivin mRNA levels. This phenomenon
has recently been demonstrated in patients with esophageal
cancer. Yang and colleagues20 reported that survivin expres-
sion in esophageal tumors was higher in tumors with mutant
p53 than in those with wild-type p53. In our report, overex-
pression of wild-type p53 had no effect on survivin protein
expression, suggesting significant posttranscriptional stabili-
zation of either survivin mRNA or the survivin protein itself
in TE7 cells.
CONCLUSIONS
Loss of p53 expression and overexpression of theWnt sig-
naling pathway (b-catenin) have been described in a number
of different cancers. However, the downstream effects of
these mutations seem to be tissue specific. The results pre-
sented in this article demonstrate that loss of p53 contributes
to the survivin-mediated resistance to apoptosis observed in
TE7 cells and that b-catenin/TCF-mediated transcription of
the survivin gene does not significantly influence survivin
expression in these cancer cells. Further analysis with other
negative regulators of survivin transcription, such as Krup-
pel-like factor 4, will be important to quantify the importance
of p53 loss.21 Survivin protein levels did not change despite
p53 overexpression with a resulting 50% decrease in survi-
vin promoter activity. This finding prompts speculation that
posttranscriptional regulation of survivin expression in TE7
cells seems to stabilize either survivin mRNA or the survivin
protein itself. The relative roles of co-factors, such as PLK1,232 The Journal of Thoracic and Cardiovascular Surgwhich bind to survivin and enhance its antiapoptotic func-
tion, remain to be clarified.22 Additional studies identifying
additional mechanisms for this posttranscriptional regulation
of survivin may yield potential therapeutic targets for revers-
ing survivin-mediated resistance to apoptosis in esophageal
cancer cells.References
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